Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-06-26
2010-06-29
Seaman, D. Margaret (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S094000
Reexamination Certificate
active
07745628
ABSTRACT:
The present invention relates to a method for obtaining Dolasetron that comprises: a) Esterification of the alcohol of formula (IV) with indole-3-carboxylic acid (compound (III)) or a reactive derivative thereof, to give a compound of formula (V), followed by step b) which includes Dieckmann reaction of the intermediate (V), by reaction with a strong organic or inorganic base, to give the intermediate (VI), and step c) which comprises dealcoxycarbonylation of the intermediate (VI) to give Dolasetron base and, if desired, a pharmaceutically acceptable salt thereof, hydrates or solvates of the base of said salt. The invention also relates to the intermediates (V) and (VI), and methods for obtaining them. With the method of the present invention Dolasetron is obtained at industrial scale with good yields, with decreased use of reactants and solvents, while said method is also of greater atomic efficiency.
REFERENCES:
patent: 5561149 (1996-10-01), Azria et al.
patent: 87116119.6 (1988-05-01), None
patent: 89107764.6 (1989-11-01), None
patent: 2006056081 (2006-06-01), None
patent: WO 2006/056081 (2006-06-01), None
Andrés Juan Antonio Pérez
Barjoan Pere Dalmases
Inke, S.A.
O'Connor Cozen
Rahmani Niloofar
Seaman D. Margaret
LandOfFree
Method for obtaining a pharmaceutically active compound,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for obtaining a pharmaceutically active compound,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for obtaining a pharmaceutically active compound,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4156288